Literature DB >> 1872497

Management of septic shock: present and future.

J E Parrillo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872497     DOI: 10.7326/0003-4819-115-6-491

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  More on pathogenesis and treatment of septic shock.

Authors:  D Fumarola; S Pece
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

2.  The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome.

Authors:  A Myc; J Buck; J Gonin; B Reynolds; U Hammerling; D Emanuel
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

3.  Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.

Authors:  Sigrun Friesecke; Stephanie-Susanne Stecher; Stefan Gross; Stephan B Felix; Axel Nierhaus
Journal:  J Artif Organs       Date:  2017-06-06       Impact factor: 1.731

Review 4.  C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Authors:  C E Hack; A C Ogilvie; B Eisele; A J Eerenberg; J Wagstaff; L G Thijs
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.

Authors:  Thomas B Elliott; David L Bolduc; G David Ledney; Juliann G Kiang; Oluseyi O Fatanmi; Stephen Y Wise; Patricia L P Romaine; Victoria L Newman; Vijay K Singh
Journal:  Int J Radiat Biol       Date:  2015-06-08       Impact factor: 2.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.